[Effect of different cytokine combinations on the expression of CD49d and CXCR4 and ex vivo expansion of umbilical cord blood mononuclear cells].
This study was purposed to explore the effect of different cytokine combinations on the expansion of the mononuclear cells drived from umbilical cord blood (CB) ex vivo and expression of CXCR4 and CD49d on CD34+ cells after expansion. Human fresh CB mononuclear cells were cultured in serum-free and stroma-free medium containing different combinations of cytokine for 7 days. At day o and 7, the total cells were counted, CD34+ cells and CD34+CXCR4+, CD34+CD49d+ cells were assayed by flow cytometry, and CFU were determined. According to the different combinations of cytokine, experiments were divided into four groups: control, SF group (SCF + FL), SFT group (SCF + FL + TPO) and SFT6 group (SCF + FL + TPO + IL-6). The results showed that the SF (SF group) combination supported only low expansion of total cells, CD34+ cells and CFU. The addition of TPO in SF group restored UCB stem/progenitors expansion to a higher level than that in SF group, while there was no difference between groups SFT and SFT6 (P > 0.05). The cytokine combinations in groups SF, SFT and SFT6 all could upregulate the expression levels of CD49d and CXCR4 on expanded cord blood CD34+ cells, but there were no significant differences between groups SF, SFT and SFT6 (P > 0.05). It is concluded that SCF + FL has no strong synergistic effects on primitive hematopoietic cells. TPO plays an important role in enhancing expansion of umbilical cord blood hematopoietic cells, while IL-6 only shows a neutral effect on it. SCF + FL + TPO combination not only promotes progenitor cells expansion but also upregulates the expression of CD49d and CXCR4 on CD34+ cells from cord blood.
Mao
Ping
P
Department of Hematology, The Affiliated First Municipal People's Hospital of Guangzhou Medical College, Guangzhou 510182, China.
Xu
Li
L
Mo
Wen-Jian
WJ
Yin
Yi
Y
Xu
Yan-Li
YL
Lin
Xiu-Mei
XM
D018952:Antigens, CD34 / Q000096:biosynthesis / Q000235:genetics; D016207:Cytokines / Q000494:pharmacology*; D004357:Drug Synergism; D005312:Fetal Blood / Q000166:cytology*; D006801:Humans; D039441:Integrin alpha4 / Q000096:biosynthesis* / Q000235:genetics; D007963:Leukocytes, Mononuclear / Q000166:cytology*; D008565:Membrane Proteins / Q000494:pharmacology; D019718:Receptors, CXCR4 / Q000096:biosynthesis* / Q000235:genetics; D019089:Stem Cell Factor / Q000494:pharmacology; D013926:Thrombopoietin / Q000494:pharmacology
D018952:Antigens, CD34; D016207:Cytokines; D008565:Membrane Proteins; D019718:Receptors, CXCR4; D019089:Stem Cell Factor; C084881:flt3 ligand protein; D039441:Integrin alpha4; D013926:Thrombopoietin